Actionable news
All posts from Actionable news
Actionable news in ACOR: Acorda Therapeutics, Inc.,

Acorda Therapeutics' (ACOR) CEO Ron Cohen on Q3 2015 Results - Earnings Call Transcript


Welcome to the Acorda Therapeutics 2015 Third Quarter Update. At this time, all participants are in a listen-only mode. There will be a question-and-answer session to follow. Please be advised that this call is being taped at the Company's request.

Now, I would like to introduce your host for today's call, Felicia Vonella, Senior Director of Investor Relations at Acorda. Please go ahead.

Felicia Vonella - Senior Director, IR

Good morning, everyone. Before we begin, let me remind you that this presentation includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts regarding management's expectations, beliefs, goals, plans or prospects should be considered forward-looking. These statements are subject to risks and uncertainties that could cause actual results to differ materially. For more information on these and other risks, please refer to our filings with the SEC.

With me today are Dr. Ron Cohen, our President and Chief Executive Officer; and Mike Rogers, our Chief Financial Officer. For our Q&A session, we are also pleased to have with us Rick Batycky, our Chief...